Here is a look at the scorecard of NeuroMetrix Inc. (NASDAQ:NURO) for the most recent quarter as well as analyst estimates for the coming periods.
The company generated sales of 4.31M%, implying an increase of 0.47% compared to a similar quarter a year earlier.
To achieve the reported sales of 4.31M% for the quarter, the company incurred $2.7M in cost of goods. Therefore, after taking into account the cost of sales, NeuroMetrix Inc. emerged with a gross income of $1.61M.
Recently, NeuroMetrix, Inc. (NASDAQ:NURO) announced the launch of LivingQuell, a blog that will serve as an online resource for people affected by chronic pain – as well as the rapidly growing user base of the company’s Quell(R) Wearable Pain Relief Technology(TM).
Let?s look into the technical of the stock
The Barchart Technical Opinion rating is a 64% Sell with a Average short term outlook on maintaining the current direction. Longer term, the trend strength is Average. Long term indicators fully support a continuation of the trend.
NeuroMetrix Inc. also incurred other expenses in the course of operation. So after taking those into account as well, it exited the quarter with EPS of $(7.28). The company had 1M diluted outstanding shares at the end of the quarter.
For the next quarter, analysts on the average are modeling EPS of $-1.74.
NeuroMetrix Inc.?s cash balance at the end of the most recent quarter was 6.9M%. The company generated free cash flow of $(3.35M) during the quarter, with net operating cash flow being $(3.35M). Net change in cash was $2.95M.
What is Wall Street thinking about NeuroMetrix Inc.? So far 1 analysts have weighed on the stock, and from that it has average analyst recommendation of Buy and average price target of $16.00. To put the analyst recommendation into perspective, recommendation in the range of 1.00 – 1.24 implies a BUY recommendation, while 1.25 – 1.74 implies OVERWEIGHT. HOLD recommendation is represented by 1.75 ? 2.24, UNDERWEIGHT is represented by 2.25 – 2.74 while SELL is represented by 2.75 – 3.00.
Does NeuroMetrix Inc. have a healthy balance sheet? A look at the company’s balance sheet at the end of the most recent quarter shows that it reflects total assets of $11.09M, offset by total liabilities of $3.24M.